Novavax CEO Stanley Erck says the company is in the process of manufacturing ‘quite a bit of doses and getting them out’ and notes that the vaccine will be ‘very effective’ against the omicron strain
Novavax CEO says company at ‘tipping point’ with COVID-19 vaccine
